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KAJIAN EKSTRAK PIPER BETLE L. DAN PIPER NIGRUM L. TERPIAWAI 
TERHADAP MYCOBACTERIUM TUBERCULOSIS: PENDEKATAN SELULAR 
DAN METABOLOMIK  
 
 
ABSTRAK  
 
 
 Peningkatan kes-kes tuberkulosis (TB) yang rintang terhadap ubat-ubatan 
anti-TB telah mendorong kepada keperluan segera untuk meneroka ubat anti-TB 
yang baru yang sebaik-baiknya daripada tumbuhan ubatan tempatan. Walau 
bagaimanapun, pada dekad yang lepas tidak banyak perhatian telah diberikan ke atas 
aktiviti anti-TB tumbuhan ini dari aspek mikrobiologi dan metabolomik. 
Kajian ini dijalankan untuk menguji aktiviti antimikobakteria terhadap 
ekstrak dan fraksi Piper betle and Piper nigrum terpiawai. Ekstrak dan fraksi tersebut 
masing-masing disediakan dengan kaedah maserasi dan partisi cecair. Aktivitinya 
diuji mengguna kaedah pencairan mikro tetrazolium. Kesan fraksi aktif terhadap 
pertumbuhan Mycobacterium tuberculosis juga dikaji di bawah pemerhatian 
mikroskop cahaya dan imbasan elektron. HPLC dan gabungan spektroskopi FT-IR 
dengan PCA diguna untuk memprofilkan ekstrak dan fraksi aktif. Ujian toksisiti 
ekstrak dan fraksi dijalankan mengguna kaedah Brine Shrimp. Keputusan 
menunjukkan bahawa ekstrak P. betle dan P. nigrum memiliki aktiviti 
antimikobakteria dengan julat MIC 100 µg/ml hingga 500 µg/ml manakala julat MIC 
fraksinya ialah 25-100 µg/ml. Penilaian di bawah mikroskop cahaya menunjukkan 
bahawa kedua-dua fraksi telah memberi kesan terhadap pertumbuhan sel                             
M. tuberculosis menyebabkan hilangnya ciri ketahanan asid dan perubahan 
morfologi. Di bawah mikroskop imbasan elektron sel tersebut nampak keriput dan 
kosong kerana pelepasan bahan sitoplasma daripada sel pecah. Analisis HPLC 
menunjukkan bahawa ekstrak dan fraksi P. betle mengandungi eugenol masing-
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masing 0.065% dan 0.010%. Manakala ekstrak dan fraksi P. nigrum masing-masing 
mengandungi piperin sebanyak 1.215% dan 0.060%. Analisa prinsip komponen 
(PCA) juga telah membezakan ekstrak etanol/air (1:1) daun P. betle, ekstrak etanol 
daun P. nigrum, dan fraksi etil asetat dari kedua-dua ekstrak berasaskan spektrum 
FT-IR. Ujian toksisiti menunjukkan bahawa ekstrak aktif mempunyai toksisiti rendah 
dengan LD50 di bawah 1000 µg/ml manakala LD50 fraksi etil asetat P. betle dan P. 
nigrum masing-masing adalah 90.78 µg/ml dan 137.90 µg/ml. Kajian ini 
menunjukkan bahawa kedua-dua tumbuhan P. betle dan P. nigrum memiliki potensi 
aktiviti antimikobakteria. 
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STUDIES ON THE ACTIVITY OF THE STANDARDIZED EXTRACTS OF 
PIPER BETLE L. AND PIPER NIGRUM L. ON MYCOBACTERIUM 
TUBERCULOSIS: CELLULAR AND METABOLOMICS APPROACHES  
 
 
ABSTRACT 
 
 
 The rising of drug-resistance tuberculosis (TB) cases has prompted an urgent 
need for a new anti-TB drug preferably from local medicinal plants. However, in the 
last decade not much attention has been given to the microbiology and metabolomics 
aspects of these plants regarding to their anti-TB activity. 
This study was carried out to test the antimycobacterial activity of 
standardized extracts and fractions of Piper betle and Piper nigrum. The extracts and 
fractions were prepared with maceration and liquid-liquid partition method, 
respectively. The activity was tested using tetrazolium microdilution assay. The 
effects of the active fraction on the growth of Mycobacterium tuberculosis was also 
studied under light and scanning electron microscopy observation. HPLC and FTIR 
spectroscopy in combination with PCA were used to profile the extract and fraction. 
Toxicity testing of the active extracts and fraction was performed using Brine Shrimp 
method. The results indicated that extracts of P. betle and P. nigrum exhibited 
antimycobacterial activity with MIC values ranging from 100 µg/ml to 500 µg/ml 
while the MIC of the fractions was 25-100 µg/ml. Evaluation under light microscopy 
showed that the active fractions affected the growth of mycobacterial cells causing 
loss of acid-fastness and morphological changes. Under scanning electron 
microscopy the affected cells appeared wrinkled and empty due to release of 
cytoplasmic materials from ruptured cells. HPLC analysis showed that the extract 
and fraction of P. betle contain 0.065% and 0.010% eugenol, respectively. 
Meanwhile extract and fraction of P. nigrum contain 1.215% and 0.060% piperine, 
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respectively. Principal component analysis (PCA) was able to differentiate the leaf 
ethanol/water (1:1) extract of P. betle, the leaf ethanol extract of P. nigrum, and its 
ethyl acetate fractions based on the FT-IR spectra. Toxicity test indicated that the 
active extract had low toxicity with LD50 >1000 µg/ml while the LD50 of the ethyl 
acetate fractions of P. betle and P. nigrum were 90.78 µg/ml and 137.90 µg/ml, 
respectively. This study indicated that both P. betle and P. nigrum have potential 
antimycobacterial activity. 
1 
 
CHAPTER 1 
INTRODUCTION 
 
1.1 Tuberculosis  
Tuberculosis (TB) remains a serious problem faced by many countries in the 
world. TB is a major cause of illness and death worldwide, especially in Asia and 
Africa. Globally, 9.4 million new cases and about 1.7 million deaths from TB 
occurred in 2009. This was equal to 4,700 deaths per day or about 3 people die every 
minute due to TB. The number of new cases increased in the last decades as shown 
in Figure 1.1. Most cases were in South East Asia, Africa and Western Pacific 
regions with percentages 35%, 30% and 20% of global cases, respectively (World 
Health Organization [WHO], 2010a).  
 
 
Figure 1.1 Estimated new cases of tuberculosis in the world during 1999-2009 (WHO, 
2010a) 
 
In Malaysia, tuberculosis remains a common disease. WHO has classified 
Malaysia as an intermediate TB burden country where 63 new cases per 100,000 
people in 2009 were reported. However, it still remains a serious problem for the 
country (WHO, 2010b). The United Nation Country Team [UNCT] (2011) reported 
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the number of new cases increased from 10,873 in 1990 to 18,102 in 2009. The 
highest cases occurred in Sabah and Selangor with the number of cases 5,249 and 
2,342, respectively. In addition, TB in Malaysia belongs in the top five main 
notifiable diseases which leads to mortality (WHO, 2010b).  
The increasing incidence of tuberculosis globally is partly due to the 
HIV/AIDS pandemic. Persons with TB/HIV co-infected are more likely to develop 
active TB disease than persons without HIV. For example, the number of HIV-
positive people with infected TB increased from 0.6 million in 2007 to 1.4 million in 
2008 (WHO, 2009). TB is one cause of death in people with HIV. The death of HIV 
patients associated with TB was approximately 380,000 in 2009 (WHO, 2010c). In 
Africa, HIV is the most important factor contributing to the increase in the incidence 
of TB since 1990 (WHO, 2010d). Autopsy studies on HIV-infected adult who died in 
Africa showed that 30% to 40% was due to tuberculosis. In addition, TB killed about 
one in five of all deaths among HIV-infected children (Chaisson & Martinson, 2008). 
In Malaysia, HIV pandemic was also involved in the development of TB cases. This 
can be seen from the increasing of TB-HIV co-infection cases from 933 cases in 
2002 to 1,644 in 2009 (UNCT, 2011).  
The emergence of multidrug-resistant strains of Mycobacterium tuberculosis 
(MDR-TB) has also contributed to the expansion of the disease. According to WHO 
(2010e), MDR-TB is defined as a form of TB which is resistant to at least isoniazid 
and rifampicin. WHO estimated that 440,000 people had MDR-TB worldwide in 
2008 and that a third of them died. Almost 50% of MDR-TB cases worldwide are 
estimated to occur in China and India. In Africa, estimates show 69,000 cases 
emerged, the vast majority of which went undiagnosed. WHO also reported that in 
Russia, one in four people with tuberculosis had MDR-TB form of the disease that 
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can no longer be treated with standard drugs regimens (WHO, 2010d). MDR-TB is 
also reported in Malaysia. In 2004, the number of MDR-TB cases were 13. The 
number has increased to 17 cases in 2005 and 42 cases in 2006 (Glaziou, 2007). 
Meanwhile, 31 new cases of MDR-TB were detected in 2008 and then increased to 
55 cases in 2009 (WHO, 2010e). 
In addition, the unpleasant side-effects of TB drugs and a relatively long 
course of treatment contributed to increasing the rate of noncompliance to treatment 
regimen which in turn led to treatment failure and the development of drug resistance 
(Bisth et al., 2006). 
 
1.1.2 Genus Mycobacterium  
 Genus Mycobacterium belongs to suborder Corynebacterineae which is 
characterized by the presence of mycolic acid in the cells (Stackebrandt et al., 1997). 
The genus Mycobacterium comprises more than 100 species (Euzeby, 2011). Based 
on the rate of growth, genus Mycobacterium is classified into rapidly growing and 
slowly growing organisms. The rapid grower commonly forms colonies within 7 
days of incubation. This include Mycobacterium fortuitum, Mycobacterium 
peregrinum, Mycobacterium abscessus, Mycobacterium chelonae, and 
Mycobacterium thermoresistible. Meanwhile, the slow growers requires longer 
incubation and this include Mycobacterium kansasii, Mycobacterium marimum, 
Mycobacterium asiaticum, Mycobacterium scrofulaceum, Mycobacterium szulgai, 
Mycobacterium xenopy, Mycobacterium celatum, Mycobacterium gordonae, 
Mycobacterium flavescens, Mycobacterium avium, Mycobacterium terrae, 
Mycobacterium tuberculosis, Mycobacterium shimoidae, and Mycobacterium 
genavense  (Runyon, 1959). Both types of genus Mycobacterium are commonly 
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straight or curve rods that grow to be filaments in aerobic conditions. The cells can 
also form a branch during the growth process (Saviola & Bishai, 2006). The cells are 
then divided into two daughter cells by binary fission (Singh et al., 2010). 
One of the genus Mycobacterium related with tuberculosis disease is 
Mycobacterium tuberculosis. In the Taxonomicon Project 2000 developed by Brands 
(2011), M. tuberculosis is classified into: 
Super Kingdom : Bacteria/Monera 
Phylum  : Actinobacteria 
Class   : Actinobacteria 
Subclass  : Actinobacteridae 
Order   : Actinomycetales 
Suborder  : Corynebacterineae/Mycobacteria 
Family   : Mycobacteriaceae 
Genus   : Mycobacterium 
Species  : Mycobacterium tuberculosis 
 
 M. tuberculosis is the etiologic agent of tuberculosis in humans. The tubercle 
bacilli was found by Robert Koch in 1882 (Kanai, 1990). The discovery inspired 
scientists to find a remedy for tuberculosis. In 1921, Calmette and Guerin 
successfully isolated a live strain of Mycobacterium bovin from a cow infected with 
tuberculosis. The strain was subcultured and tested on cows and guinea pigs for 
thirteen years and then found to be less virulent for the animals. The attenuated strain 
was known as Bacille Calmette Guerin (BCG) vaccine which was used to protect 
humans against tuberculosis (WHO, 2011a). In 1944 streptomycin was discovered by 
Waksmann as the first antituberculosis drug. Since then, a number of antituberculosis 
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drugs were discovered, including para-aminosalicylic, isoniazid, pyrazinamid and 
cycloserine, ethionamide, rifampicin and ethambutol (Robson & Sullivan, 1963). 
 M. tuberculosis is a straight or slightly curved rod with length ranging from 
about 1 - 4 µm and 0.3 - 0.6 µm thick, occuring singly or in a form of strands 
(Youmans, 1979). Although M. tuberculosis belongs to gram-positive bacteria, they 
are difficult to stain with the Gram stain method. However, carbol fucshin or Ziehl-
Neelsen method is used to stain mycobacterial cells. The cells appear small red or 
pink rod under microscopic examination (Grosset et al., 2000). The bacilli grow 
slowly with the generation time in vitro being 14 - 15 hours. Colonies appear in 
about two weeks and may sometimes take up to eight weeks. The bacilli grow at an 
optimum temperature of 370C and at pH 6.4 - 7.0. However, growth does not occur 
below 250C or above 400C (Youmans, 1979). The growth of bacilli can be seen by 
morphological changes of the cells. The rod cells grow to be elongated cells after 24 
hours incubation. The cells then divide to generate new mature cells. The cells also 
branched during the dividing process to form V-shaped cells (Dahl, 2004).  
  M. tuberculosis is an obligate aerobe and grows luxuriantly in both liquid and 
solid media. The additional 0.5% glycerol as well as 0.2% sodium pyruvate improves 
the growth of M. tuberculosis (Grosset et al., 2000). The excellent media of 
Middlebrook’s 7H9, 7H10 and 7H11 for growth of the bacilli has been reported. On 
solid media, M. tuberculosis forms dry, rough, raised, and irregular colonies with a 
wrinkled surface. They are creamy white, becoming yellowish or buff coloured on 
further incubation. In liquid media without dispersing agent such as polyoxyethylene 
sorbitan monooleate (tween 80) the growth begins at the bottom, creeps up the sides 
and forms a prominent surface pellicle which may extend along the sides above the 
medium (Youmans, 1979).    
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  The growth cycle of M. tuberculosis has four major phases (Figure 1.2). 
Typical phases of mycobacteria can be demonstrated by inoculating the cells in fresh 
medium under favorable conditions and the cells are counted at frequent intervals 
(Levinson, 2006).  
 
 
Figure 1.2 Growth cycle of Mycobacterium tuberculosis (Levinson, 2006) 
 
  The first is the lag phase where by the cells adapt to new environment and the 
cell population remains unchanged. In this phase, the cells grow in size and mass, 
store nutrients, synthesize enzymes, and prepare for cell division. Subsequent phase 
of the growth is the log phase. During this phase, the cells divide at a constant rate. 
The cells also uptake and metabolize nutrients at maxiumum speed. However, when 
availability of nutrients become limited, the growth of the cells slows down. In the 
stationary phase, the multiplication rate of the cells decreases due to exhaustion of 
nutrients in the culture medium. Thus, the number of viable cells remains stationary. 
The final phase of the mycobacterial growth is the death phase. In this phase, the cell 
division completely ceases due to exhaustion of nutrients and accumulation of toxic 
products. In addition, the presence of autolytic enzymes also causes cell death 
(Todar, 2008). 
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1.1.3 Pathogenicity and Transmission of Mycobacterium tuberculosis 
  Pathogenicity is defined as the ability of the organism to produce disease in a 
host. M. tuberculosis has the ability to invade and multiply within macrophages of 
the host. The pathogenicity of M. tuberculosis often relates to the effort of the 
mycobacteria to survive in the macrophage condition. Presence of tubercle bacilli 
will stimulate the immune response of the host. The macrophages produce lysosome 
hydrolase enzyme through the fusion with lysosomes (Smith et al., 2007). In 
addition, the macrophages also create low pH condition. The presence of the enzyme 
and low pH induces killing and digestion of the mycobacteria (Jordao et al., 2008).   
 In addition, M. tuberculosis also has a cell envelope which contains a cell 
membrane and a peptidoglycan layer. The cells also have a thick hydrophobic layer 
of mycolic acids esterified to the cell wall called the mycolyl arabinogalactan. The 
unique composition of mycobacterial cell envelope is associated with its 
pathogenicity (Glickman & Jacobs, 2001). Lipoarabinomannan (LAM) is a major 
constituent of mycobacterial cell wall. The LAM has the ability to inhibit fusion of 
phagosome with lysosome. Consequently, the killing mechanism of phagosome is  
prevented (Pieters, 2008). LAM can also inactivate the macrophages through 
inhibition of interferon-γ. Interferon-γ is an activating agent of the macrophage to 
generate reactive oxygen and nitrogen which damage the mycobacteria (Meena & 
Rajni, 2010). However, the mycobacteria has the ability to develop multiple 
strategies for survival. They inactivate the reactive oxygen via formation of a 
catalase-peroxidase enzyme called KatG. The KatG is an enzyme that catalizes the 
decomposition of hydrogen peroxide to water and oxygen. In addition, mycobacteria 
will activate the proteamose function in nitric oxide stress. Proteamose is a enzyme 
that serves to eliminate protein damaged by the reactive nitrogen. Furthermore, the 
8 
 
protein will be excreted out of the cells (Pieters, 2008). On the other hand, 
mycobacteria can inhibit the acidification of macrophage through activation of the 
proton ATPase-dependent to stabilize the environment. In addition, mycobacteria can 
also recruitment and inactivate of tryptophan-aspartate containing coat protein 
(TACO) on phagosome. In the process of killing bacteria, TACO is responsible to 
deliver the bacterial toward lysosomes (cellular organelles that contain acid 
hydrolase enzymes to break down waste materials). Consequently, inactivation of 
TACO will avoid the mycobacteria to the destruction of lysosomes (Meena & Rajni, 
2010). 
  The ability of M. tuberculosis to survive and remain dormant in the host cells 
for years provides potential to be activated when the immune system becomes 
inadequate. TB is a communicable disease which spreads via aerosols. During 
coughing, sneezing, talking or spitting, people infected with TB produced droplet 
nuclei containing M. tuberculosis into the air (Varaine et al., 2010; Youmans, 1979). 
Infection occurs when a susceptible person inhales the droplet nuclei. The droplet 
enters the body through the mouth or nasal passages, upper respiratory tract, and 
bronchi to reach the alveoli. The person will become sick within 2 – 12 weeks after 
infection depending on the immune response (Jensen et al., 2005).   
   
1.1.4 Multidrug Resistant Tuberculosis 
Multidrug resistant tuberculosis (MDR-TB) is defined as resistant to at least 
isoniazid and rifampicin (Spardling & Ridzon, 2004). Two broad categories of 
MDR-TB are recognized, that is primary and acquired. Primary resistance refers to 
drug resistance of the bacilli from a patient who has never received treatment. 
Acquired or secondary resistance refers to resistance of the bacilli after exposure to 
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an antimicrobial agent, whereby the mutant bacilli have been selected for survival 
(Goble, 2000). The acquired resistance usually occurs as a result of non-adherence to 
TB drug regiments or treatment failure (Maurya et al., 2011). The resistance is 
associated with the use of a single TB drug to treat TB which is not enough to kill 
tubercle bacilli. In addition, poor compliance due to several reasons such as 
alcoholism, homelessness, drug addiction, and side effects of TB drugs also 
contribute to the acquired resistance. Other contributing factors include inadequacy 
of TB treatment management and quality of the antituberculosis drug (Jain & Dixit, 
2008). 
The other type of resistance is extensively drug resistant tuberculosis (XDR-
TB). According to WHO (2010f), the XDR-TB is a form of tuberculosis caused by  
M. tuberculosis that is resistant to at least isoniazid and rifampicin plus any 
fluoroquinolone and any injectable second-line anti TB drug such as amikacin, 
kanamycin, and capreomycin. XDR-TB commonly occurs because of misuse and 
mismanagement of the second-line TB drugs. This may be contributed by several 
factors such as patients do not complete their second line regimens or due to 
inappropriate dose regiment and poor quality of drugs given by the health-care 
providers (WHO, 2007a).  
WHO estimates the emergence of 25,000 cases of XDR-TB every year. There 
are 27 high XDR-TB burden countries such as Argentina, Canada, United States, 
France, Germany, Armenia, Russia Federation, China, India, Israel, South Africa, 
Thailand, Myanmar, and Australia. Meanwhile in Malaysia, as yet, there is no report 
of XDR-TB cases (WHO, 2011b).  
 The emergence of resistance to anti-tuberculosis drugs is recognized as a 
phenomenon that cannot be avoided. The resistance not only poses a public health 
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threat to successful control of TB but it also complicates the approaches to treatment 
of patients (Heifets & Cangelosi, 2009). The use or misuse of anti-tuberculosis drugs 
over the years has led to increasing prevalence of drug resistance, thus development 
of new effective drugs has become urgent (Cox et al., 2003; Nachega & Chaisson, 
2003). In addition, the use of antituberculosis drug for MDR-TB and XDR-TB need 
longer duration treatment (2 years) which is costly and toxic (WHO, 2008a).  
 
1.1.5 Treatment of Tuberculosis 
 Treatment of tuberculosis with effective chemotherapy can reduce the 
population of viable bacilli and consequently reduce the risk of transmission. Five 
drugs currently used as essential in the management of tuberculosis, which are also 
known as first line TB-drugs are isoniazid, rifampicin, pyrazinamid, streptomycin, 
and ethambutol. Other drugs such as para-aminosalicylic acid, kanamycin, 
cycloserin, capreomycin, viomycin, and ethionamide are used to treat patients with 
multiple drug resistant disease. These drugs which are known as second line TB-
drugs are more expensive and more toxic than the first line (WHO, 1991). 
The WHO-recommended strategy for tuberculosis control is directly 
observed treatment short-course (DOTS). The DOTS strategy is a short course 
chemotherapy based on appropriate diagnosis of TB with a minimum of six months. 
Chemotherapy for TB uses standardized drug regimens of fixed-dose combination 
(FDC) for all patients (WHO, 2002a). Treatment regimens for TB using FDC depend 
on categories of TB cases. The recommended treatment of first-line anti TB drug are 
presented in Tables 1.1 and Table 1.2 (WHO, 2002b). 
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Table 1.1 Recommended treatment regimens for tuberculosis adult patients 
 
Patient 
body 
weight (kg) 
Initial phase Continuation phase 
2 months 4 months or 6 
months* 
Daily or Daily or 3 times per 
week Daily 
or 3 times 
per week Daily 
RHZE 
(150+75+400+275) 
mg 
RHZ 
(150+75+400) 
mg 
RHZ 
(150+150+500) 
mg 
RH 
(150+75) 
mg 
RH 
(150+150) 
mg 
EH 
(400+150) 
mg 
30-39 2** 2 2 2 2 1.5 
40-54 3 3 3 3 3 2 
55-70 4 4 4 4 4 3 
71 and more 5 5 5 5 5 3 
R: rifampicin; H: isoniazid; Z: pyrazinamide; E: ethambutol 
*   4RH may be replaced by 6 EH daily when supervision of treatment is not possible. However, preliminary data from a recent 
clinical trial have shown that 6EH is much less effective than 4RH in terms of cure, with higher failure and relapse rates. 
** Number of drug FDC tablets. 
 
 
Table 1.2 Recommended treatment regimens for tuberculosis children patients 
 
Patient body 
weight (kg) 
Initial phase Continuation phase 
2 months 4 months 
Daily Daily or 3 times per week 
RHZ 
(60+30+150) mg 
RH 
(60+30) mg 
RH 
(60+60) mg 
<7 1* 1 1 
8-9 1.5 1.5 1.5 
10-14 2 2 2 
15-19 3 3 3 
20-24 4 4 4 
25-29 5 5 5 
R: rifampicin; H: isoniazid; Z: pyrazinamide; E: ethambutol. 
* Number of drug FDC tablets. 
 
Directly observed treatment (DOT) means the patient swallows the FDC 
tablets in front of a trained health worker. This proposes to ensure the TB patient 
takes the right drugs, in the right doses, at the right intervals. Treatment of TB is 
carried out in two phases namely initial and continuation phase. In the initial phase, 
the drug regimen for new TB adult patient consisted of rifampicin, isoniazid, 
pyrazinamide and ethambutol (RHZE). However for children, only 3 drugs 
combination without ethambutol (RHZ) is given. In relapse case or treatment failure, 
ethambutol of RHZE combination is usually replaced with streptomycin. The 
duration of the initial phase is 2 months. In the continuation phase, all TB patients 
receive rifampicin and isoniazid combination for 4 months. Rifampicin usually 
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replaces ethambutol when there is a hypersensitivity reaction. In this case, the 
treatment duration is 6 months (WHO, 2002b).   
The main problem related to FDC regimen is non-compliance of TB patients. 
This is because the regimen needs long duration periods to complete the TB 
treatment (Du Toit et al., 2006). Besides, the patient has to consume a large number 
of tablets every day and this may create frustration among the patients (Panchagnula 
et al., 2003). In addition, most anti-TB drugs can cause liver damage and renal 
failure. Once the patient experiences allergic or side-effects to any of drugs, the FDC 
regimen must be stopped or replaced with other anti-TB drugs (Bhowmik et al., 
2008).  
Although the chemotherapy is effective for treatment of tuberculosis but 
development of drug resistance and tolerance of the anti-TB drug used remain 
serious problem. The resistance is contributed by several factors such as poor 
compliance and non-adherence to drug regiments as well as failure of drug 
prescription and therapy monitoring (Rastogy & Falkinham, 1996; Schaberg, 1995; 
Horne, 1994). Hepatotoxicity, a side effect of anti-TB drugs particularly INH is a 
major factor in tolerance of the tuberculosis therapy. INH is most widely associated 
with incidence of hepatotoxicity during patient receiving chemotherapy. Therefore, 
new drugs without serious adverse effects are urgently needed to control tuberculosis 
disease (Schaberg, 1995). In addition, there has been no new anti-TB drugs 
introduced since ethambutol was discovered in 1957. Thus, there is an urgent need to 
search and develop new effective anti-TB drugs (Gautam et al., 2007; Tomioka & 
Namba, 2006).  
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1.2 Susceptibility Testing  
 Susceptibility testing is defined as measurement of the ability of an 
antimicrobial agent to kill or inhibit the growth of bacteria in vitro (Vandepitte et al., 
2003). Bell et al. (2009) stated that the susceptibility of drug is usually made on the 
basis of breakpoints which is known as minimum inhibitory concentration (MIC). 
Andrews (2001) and Smaill (2000) defined the MIC as the lowest concentration of a 
drug that inhibits visible bacterial growth. Several susceptibility testing methods to 
determine the MIC value of antimycobaterial activity of natural products were 
introduced, namely: broth dilution, proportional, disk diffusion, radiometric, and 
colorimetric method. 
 
1.2.1 Broth Dilution  
Macrobroth or tube-dilution method is carried out by preparing two fold 
serial dilution of test sample in test tubes containing liquid medium. A bacterial 
suspension of 1-5 x 105 CFU/ml is added in these tubes. MIC determined after 
incubation is based on turbidity of visible bacterial growth (Jorgensen & Ferraro, 
2009). The turbidity is recorded by measuring the optical density at 405 nm and 
growth curve plots for all concentration of the sample (Figure 1.2). The MIC is 
defined as the lowest concentration of the sample with no visible or detectable 
mycobacteria growth (Cos et al., 2006). 
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Figure 1.3 Growth curve with plot optical density vs concentration of drug (Cos et al., 2006) 
 
 The advantages of this method are that it is easy to perform, cheap, rapid, and 
the results are reproducible. However, the preparation of the drug solutions is tedious 
and could lead to error. In addition, this method requires the use of large amount of 
reagents (Jorgensen & Ferraro, 2009). 
 
1.2.2 Proportional Method  
This method is carried out by preparing different concentrations of test 
sample in agar plate. An inoculum of mycobacteria is transferred to the plate. After 
incubation, viable colony of the bacterial growth is counted for each concentration of 
test compound (Mendoza, 1998). MIC is defined as the lowest concentration of the 
sample which caused a 10-2 reduction in the viable counts compared to the respective 
control (Klingeren et al., 2007). The advantage of this method is that it can be used 
for testing of several mycobacterial isolates simultaneously. However, this method is 
time consuming (Mendoza, 1998). 
 
 
 
1.2.3 Disk Diffusion  
Disk diffusion method is prepared by placing a paper disc containing certain 
concentration of test sample on agar plate surface previously inoculated with 
mycobacteria. After incubation, mean diameters of growth inhibiton zone are 
recorded. Interpretation 
method as describe in Figure 1.3 (Vandepitte 
method is that it does not 
interpret. However, this method
2009). 
 
Figure 1.4 Interpretation of zone sizes by their relationship to the MIC
2003) 
 
1.2.4 Radiometric 
Radiometric is a method to detect the presence of mycobacteria based on 
their metabolism. This method is performed by preparing serial 
sample in liquid medium containing 
metabolize the 14C to carbon dioxide (
instrument and reported as growth index (GI). This method can produce 
15 
of zone sizes and the MIC is determined using 
et al., 2003). The advantage
require any special equipment and the results are easy to 
 remains manually performed (Jorgensen & Ferraro, 
 
 (Vandepitte et al., 
dilut
14C-palmitic acid. The mycobacteria will 
14CO2) which is measured by BACTEC 460 
Kirby–Bauer 
 of this 
ion of test 
accurate 
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results in around 5 days (Ramachandran & Paramasivan, 2003). The test is 
interpreted on the day the GI in inoculum control diluted 1:100 reaches 20 or more. 
MIC is defined as the lowest concentration of the sample that inhibited more than 
99% of the mycobacterial population. It was obtained as the lowest concentration in 
which the daily GI increases were less than the control and the final GI of the sample 
was not greater than 50 at the last day of experiment (Siddiqi et al., 1993). The main 
disadvantage is that this method is more expensive than conventional methods 
(Newton et al., 2000).   
 
1.2.5 Colorimetric Method 
Other method which becomes popular is calorimetric method. This method 
needs several days for growth of the bacteria but does not require radioactive 
substrate as the BACTEC (Newton et al., 2000). In addition, colorometric method is 
easy to perform, rapid, and inexpensive (Caviedes et al., 2002; Danizot & Lang, 
1986; Mosmann, 1983). The advantage of this method is the visual observation can 
be affected by natural dark color of sample test. It is lead to the results are difficult to 
interpret and could lead to error (Primm & Franzblau, 2007). Colorimetric methods 
for detecting drug susceptibility of M. tuberculosis are generally based on the 
reduction of a reduction-oxidation (redox) indicator added to a liquid culture 
medium. The susceptibility of drugs is detected by a change in colour of the 
oxidation-reduction indicator, which is directly proportional to the number of viable 
mycobacteria in the medium (Yajko et al., 1995). There are several redox indicators 
that can be used for colorimetric method such as resazurin, nitrate, and tetrazolium 
salt.  
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Resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide) is a blue dye. 
Presence of growth of mycobacterial cell is indicated by the colour change from blue 
to pink. For susceptibility testing of mycobacteria, MIC of anti-TB drug is defined as 
the lowest drug concentration that prevented the colour change of resazurin (Nateche 
et al., 2006).  
Susceptibility testing of mycobacteria is also evaluated using nitrate as redox 
indicator. Living mycobacterial cell converts nitrate (NO3-) to nitrite (NO2-) that 
indicates pink – violet color when added with Griess reagent prepared by mixing 
concentrated hydrochloric acid, sulphanilamide, and n-1-naphthylethylenediamine 
dihydrochloride solution. Antimycobacterial activity of a drug is interpreted if there 
is no color change (Coban et al., 2004).  
Tetrazolium salt is used as the indicator since bacteria or fungi convert them 
to colored formazan derivatives that can be observed by colour change from yellow 
to purple (Grare et al., 2008). In order to implement a rapid and inexpensive method 
for determining the MICs of several anti-TB drugs, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) assay has also been formatted as a microplate-
based test and evaluated with clinical isolates of M. tuberculosis (Morcillo et al., 
2004).  
MTT has been used widely for measuring cell proliferation and viability. 
Basically, the MTT is a yellow compound that changes to purple when reduced by 
dehydrogenase of active cells (Palomino et al., 2007). MTT is transported into the 
cell through endocytosis mechanism. Nicotinamide adenine dinucleotide plus 
hydrogen (NADH) and nicotinamide adenine dinucleotide phosphate plus hydrogen 
(NADPH), two enzymes continuously available in the living cell during cellular 
metabolism reduce the MTT to MTT formazan (Metzler, 2002). Furthermore, the 
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MTT formazan accumulated in the endosome compartment is transported to the cell 
surface and produces purple color when react to tetrazolium (Liu et al., 1997). 
Reduction of MTT to MTT formazan is described in Figure 1.4. 
 
 
Figure 1.5 Reduction of MTT to MTT formazan 
 
1.3 Uses of Traditional Medicine for Treatment of Tuberculosis 
 According to WHO (2008b), traditional medicine was defined as the sum 
total of knowledge, skills and practices based on the theories, beliefs, and 
experiences indigenous to different cultures that are used to maintain health, as well 
as to prevent, improve or treat physical and mental illness. Medicinal plant and 
bioactive compounds have been used widely in the world. Approximately 80% of 
world’s population still rely on medical plants for their primary healthcare (WHO, 
2001). In Malaysia, Arabic Unani medicine and galenic philosophy are fundamental 
of Malaysian traditional medicine. It is rapidly progressed by influencing of other 
practices of Chinese, Indian, Indonesian and indigenous poeple traditional medicine. 
Chants, prayers, massage, abstinence and natural resources derived from plants are 
commonly used for cure several health problems (Jamal, 2006). More than 10,000 
traditional medicine practitioners were currently reported by the government of 
Malaysia. Approximately, seventy percent of Malaysian population used traditional 
medicine for treat their health problems. However, there are a few of traditional 
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medicine types which are integrated to public hospital practices such as massage, 
acupuncture and herbal oncology (Abuduli et al., 2011). 
Traditional medicines are used to cure tuberculosis in many countries. For 
example, in Indonesia, Artocarpus elasticus Reinw (Moraceae) is used to treat 
tuberculosis. The mature leaves are dried, crushed and then mixed with spices. The 
mixture is then cooked with water to obtain a decoction (Setyawati, 2009). In 
addition, Pleomele angustifilia (Agavaceae) has also been used for TB treatment. 
The leaf of this plant is boiled with water and then the water is taken (Roosita et al., 
2008).  
  In addition, Mohamad et al. (2011) reported that Flemingia strobilifera 
(Fabaceae), Licuala spinosa Thunb. (Arecaceae), Tabernaemontana coronaria 
(Apocynaceae), and Tenospera crispa (Menispermaceae) have been used in the 
Malaysian community for tuberculosis treatment. According to Mat-Saleh and Latif 
(2002), the part used from these plants is commonly the leaf or stem. The people 
prepare the concoction by boiling the plant with water or soaking in water overnight 
to get a decoction. 
McGaw et al. (2008) reported a large number of plants in South Africa that 
are used as traditional medicine for the treatment of tuberculosis. They include the 
family of Aizoaceae, Alliaceae, Asclepiadaceae, Asparagaceae, Asteraceae, 
Combretaceae, Euphorbiaceae, Fabaceae, Geraniaceae, Moraceae, Myrtaceae, 
Polygonaceae, Rubiaceae, Santalaceae, and Sapindaceae. The plants are commonly 
employed in aqueous infusions and then administered orally. 
In Uganda, about 88 plants used for tuberculosis were identified. The most 
frequently used are Eucalyptus spp., Ocimum suave Willd., Persea americana Mill., 
Acacia hockii De Wild., Warburgia salutaris (G. Bertol.) Chiov., Zanthoxylum 
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chalybeum Engl., and Momordica foetida Schum. The people usually prepare their 
concoctions by decoction or infusion. Materials such as honey, rock salt, sugar, and 
Zingiber officinale Rosc. are also added in the concoction as preservatives. It is taken 
3 times per day with dose 1 – 2 teaspoons for 1 – 12 weeks or until the patient 
recovers (Tabuti et al., 2010). 
 
1.4 Plants as Antimycobacterial Agents Resources 
 The literature on the antibacterial, antituberculosis, antifungal, and antiviral 
properties of plant extracts has been progressed over the past decade (Newton et al., 
2000). Interestingly, some of the plants used for TB in traditional medicine proven to 
have antimycobacterial activity. For example, about 149 species of Indian medicinal 
plants showed close correlation with ethnomedicinal uses for TB or related diseases 
(Gautam et al., 2007). 
 In Malaysia, 38 plants have been identified to have antimycobacterial activity 
with MICs ranging from 1600 – 400 µg/ml. The highest activity was demonstrated 
by Angiopteris evecta (J.R. Forst.) Hoffm. (Marattiaceae) with MIC value of 400 
µg/ml (Mohamad et al., 2011). 
 McGaw et al. (2008) reported about 74 extracts derived from South African 
plants demonstrated antimycobacterial activity. The most active of the plant extracts 
has MIC value of 100 µg/ml, such as Helichrysum caespitatum, Nidorella anomala 
Steetz., Chenopodium ambrosioides Linn., Euclea natalensis A. de Candolle., 
Croton pseudopulchellus Pax., Ekebergia capensis Sparrm., Salvia radula, and 
Polygala myrtifolia Linn. In addition, Lall and Meyer (1999) also reported fourteen 
acetone extracts of South African medicinal plants showed inhibitory activity against 
mycobacterial. Some of them including Chenopodium ambrosioides, Ekebergia 
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capensis, Euclea natalensis, Helichrysum melanacme, Nidorella anomala, and 
Polygala myrtifolia were also shown to have activity against the resistant strain of  
M. tuberculosis with the MIC values ranging from 100 – 1000 µg/ml.  
Jimenez-Arellanes et al. (2003) also reported 22 plants derived from Mexican 
medicinal plants indicated to have antimycobacterial activity with MIC value in the 
range of 50 – 200 µg/ml. Interestingly, among the plants, the hexane extract of 
Lantana hispida demonstrated potential activity when tested against the resistant 
strain of M. tuberculosis with the MIC values ranging from 25 – 100 µg/ml.  
Meanwhile, Duke (1992) described more than 230 plants from various 
families that were used to treat tuberculosis. Some of them belong to Fabaceae, 
Asteraceae, Liliaceae, Acanthaceae, Piperaceae, Minispermaceae, and Araceae. For 
example, Andrographis paniculata, Allium sativum, Artemisia annua, Aloe vera, 
Morinda citrifolia, and several Piper species.  
According to Gautam et al. (2007), in India, there were 25 most active plant 
species against mycobacteria such as Acorus calamus, Adhatoda vasica, Allium 
sativum, Alpinia galanga, Artocarpus lakoocha, Caesalpinia pulcherrima, 
Calotropis gigantea, Canscora decussata, Cinnamomum camphora, Cissampelos 
pareira, Citrullus colocynthis, Erythrina variegata, Glycyrrhiza glabra, Inula 
racemosa, Juniperus excelsa, Morinda citrifolia, Ocimum sanctum, Piper cubeba, 
Plantago major, Portulaca oleracea, Psoralea corylifoila, Sassurea lappa, Solanum 
dulcamara, Tinospora cordifolia, and Zingiber officinale. These plant species 
showed antimycobacterial activity with MIC values ranging from 10 to 100 µg/ml 
and the active compounds from 11 of these species have been isolated with MIC 
values ranging from 1 to 50 µg/ml. 
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Potential activity of naturally occurring compounds and synthetic analogues 
as well as extracts from plants and microorganisms against M. tuberculosis have also 
been reported by Okunade et al. (2004). The activity was shown in the MIC range of 
1.56 – 100 µg/ml. Several phytochemicals which have potential antimycobacterial 
agents were also reported including ergosterol-5,8-endoperoxide from Arjuga 
remota, with MIC value of 1 µg/ml (Cantrell et al., 1999), a jujubogenin saponin 
from Colubrina retusa with the MIC of 10 µg/ml (ElSohly et al., 1999), and 
phenylethanoids from Buddleja cordata with the MIC of 64 µg/ml (Avecedo et al., 
2000).  
 Compounds derived from plants that have potential as antitubercular agents 
include berberine, lichoisoflavone, erygibisoflavone, phaseollidin, erythrabyssin II, 
and tryptanthrin with MIC values in the range of 1 – 25 µg/ml (Mitscher & Baker, 
1998). Two of the tannin groups identified as ellagitannin and punicalagin isolated 
from Combretum molle exhibited antimycobacterial activity with the MIC ranging 
from 600 – 1,200 µg/ml (Asres et al., 2001). Essential oils of Achyrocline alata and 
Swinglea glutinosa also showed activity against M. tuberculosis with MIC values of 
62.5 µg/ml and 100 µg/ml, respectively (Bueno-Sanchez et al., 2009).  
 A drug is considered ideally effective if it has low adverse-effects, has good 
pharmacokinetic properties and cheap. Therefore, many studies have been made to 
discover antimycobacterial drugs from natural products. There is an increasing 
interest in natural products as potential therapeutic agents, including plant extracts. 
Developing new drugs based on natural product derived from plant indicates good 
prospect. This is triggered by the emergence of techniques to isolate and optimize the 
structure of lead compounds (Bisth et al., 2006). 
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Plants are incredible sources of various types of molecules that can be used as 
medicine, including the treatment of tuberculosis. A number of extracts and pure 
compounds derived from plant indicated potential activity against Mycobacterium. 
The metabolites such as alkaloids, phenolics, steroids, and terpenoids are known to 
have activity against mycobacteria. These phytochemicals provide useful prospect 
for the development of new antitubercular drugs which may act on newer target. It 
also will expand opportunities to discover the new generation of antitubercular 
agents (Negi et al., 2010). 
Plants have been used worldwide in traditional medicines for the treatment of 
different diseases. The large diversity of plants in the world provide a basis of 
selecting the starting point for new drug discovery, especially novel lead compounds. 
The discoveries including searching for new anti-TB agents can be made by 
evaluating anti-TB of the plants based on the traditional use (Kobarfard, 2004).  
One of the important groups of plant which have potential as 
antimycobacterial agent sources is family Piperaceae. Interestingly, several species 
of this family have shown activity against M. tuberculosis with the MIC values                
≤ 100 µg/ml. As an extension of the above finding, in this study, we have focused on 
the antimycobacterial activity of Piper species at the cellular level to know its 
mechanism of action. In addition, we have also used the approach of metabolomics 
to obtain a picture of the plant metabolite responsible for the activity. To the best of 
our knowledge, this is the first study ever conducted in Malaysia.   
 
1.4.1 Family Piperaceae  
The family Piperaceae consists of 10 genera and about 2,000 species of 
tropical plant of which about 30 species are used in health system in Asia-Pacific 
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region (Wiart, 2006). These plants are widely distributed in tropical and subtropical 
regions of the world mainly in Asian tropics, African tropics, South Pacific, Central 
America, Atlantic forest, Choco region, Andes region, and Amazonia. The greatest 
diversity occurs in American tropics and Southern Asia where the economically 
important species Piper nigrum Linn. and Piper betle Linn. originated (Jaramillo & 
Manos, 2001). The genus Piper is usually used as food flavouring agents as well as 
in traditional medicines, and as pest control agents (Parmar et al., 1997).  
Piper species are commonly grown as herbs, woody vines, and small trees. 
The leaves have a pungent flavor and grow singly. The plant also has numerous 
flowers which lack petals. The stems are usually creeping and climbing (Chaveerach 
et al., 2006). Most species of Piper are aromatic because of the essential oil cells in 
their tissues (Greig, 2004). 
The family Piperaceae has widely been used in traditional medicinal system 
in many countries. The use of the family Piperaceae by commmunities are 
commmonly to treat gastric ulcers (Braga et al., 2007; Hammond et al., 1998), 
wound healing (Schmidt et al., 2009), malaria (Braga et al., 2007), rheumatism 
(Sanz-Biset et al., 2009; Zheng & Xing, 2009), cough (Green et al., 2010; Roosita et 
al., 2008; Hilgert, 2001), fever (Ong & Nordiana, 1999), central nervous system 
disorder (Tene et al., 2007), asthma (Savithramma et al., 2007; Ong & Nordiana, 
1999), leprosy (Green et al., 2010), and tuberculosis (Gale et al., 2007; Billo et al., 
2005).   
  Piperaceae species have also been investigated by many researchers for a 
number of pharmacological activities such as antioxidant (Yamaguchi et al, 2006; 
Dasgupta & De, 2004), antialergic (Wirotesangthong et al., 2008), antidiabetic 
(Arambewela et al., 2005), antileishmanial (Rocha et al., 2005), insecticidal agent 
